199 related articles for article (PubMed ID: 22905681)
1. Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease.
Zizzo C; Colomba P; Albeggiani G; Gallizzi R; Iemolo F; Nuzzo D; Vasto S; Caruso C; Duro G
Clin Genet; 2013 Jun; 83(6):576-81. PubMed ID: 22905681
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey.
Huzmeli C; Candan F; Alaygut D; Bagci G; Akkaya L; Bagci B; Sozmen EY; Kurtulgan HK; Kayatas M
Biochem Genet; 2016 Aug; 54(4):448-456. PubMed ID: 27105876
[TBL] [Abstract][Full Text] [Related]
3. Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis.
Kümpfel T; Gerdes LA; Wacker T; Blaschek A; Havla J; Krumbholz M; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Mult Scler; 2012 Sep; 18(9):1229-38. PubMed ID: 22337722
[TBL] [Abstract][Full Text] [Related]
4. Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations.
Cazeneuve C; Hovannesyan Z; Geneviève D; Hayrapetyan H; Papin S; Girodon-Boulandet E; Boissier B; Feingold J; Atayan K; Sarkisian T; Amselem S
Arthritis Rheum; 2003 Aug; 48(8):2324-31. PubMed ID: 12905488
[TBL] [Abstract][Full Text] [Related]
5. MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience [corrected].
Yigit S; Bagci H; Ozkaya O; Ozdamar K; Cengiz K; Akpolat T
J Rheumatol; 2008 Jan; 35(1):106-13. PubMed ID: 18061974
[TBL] [Abstract][Full Text] [Related]
6. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients.
Federici L; Rittore-Domingo C; Koné-Paut I; Jorgensen C; Rodière M; Le Quellec A; Touitou I
Ann Rheum Dis; 2006 Nov; 65(11):1427-32. PubMed ID: 16707534
[TBL] [Abstract][Full Text] [Related]
7. Familial Mediterranean fever with a single MEFV mutation: where is the second hit?
Booty MG; Chae JJ; Masters SL; Remmers EF; Barham B; Le JM; Barron KS; Holland SM; Kastner DL; Aksentijevich I
Arthritis Rheum; 2009 Jun; 60(6):1851-61. PubMed ID: 19479870
[TBL] [Abstract][Full Text] [Related]
8. Screening for Fabry's disease in a high-risk subpopulation of FMF.
Maller T; Ben-Zvi I; Lidar M; Livneh A
Eur J Med Res; 2022 Oct; 27(1):210. PubMed ID: 36271470
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation?
Ozen S; Bakkaloglu A; Yilmaz E; Duzova A; Balci B; Topaloglu R; Besbas N
J Rheumatol; 2003 Sep; 30(9):2014-8. PubMed ID: 12966608
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-associated speck-like protein containing a CARD (ASC) expression profiles in familial Mediterranean fever (FMF) patients with different MEFV mutation patterns.
Nalbantoglu S; Tanyolac B; Berdeli A
Scand J Rheumatol; 2013; 42(2):159-62. PubMed ID: 22934972
[TBL] [Abstract][Full Text] [Related]
11. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
Rosa Neto NS; Bento JCB; Pereira RMR
Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
[TBL] [Abstract][Full Text] [Related]
12. Common MEFV mutation analysis in Iranian Azeri Turkish patients with familial Mediterranean fever.
Esmaeili M; Bonyadi M; Rafeey M; Sakha K; Somi MH
Semin Arthritis Rheum; 2008 Apr; 37(5):334-8. PubMed ID: 18006045
[TBL] [Abstract][Full Text] [Related]
13. Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients.
Yigit S; Karakus N; Tasliyurt T; Kaya SU; Bozkurt N; Kisacik B
Gene; 2012 Sep; 506(1):43-5. PubMed ID: 22771921
[TBL] [Abstract][Full Text] [Related]
14. Clinical disease among patients heterozygous for familial Mediterranean fever.
Marek-Yagel D; Berkun Y; Padeh S; Abu A; Reznik-Wolf H; Livneh A; Pras M; Pras E
Arthritis Rheum; 2009 Jun; 60(6):1862-6. PubMed ID: 19479871
[TBL] [Abstract][Full Text] [Related]
15. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever.
Giaglis S; Papadopoulos V; Kambas K; Doumas M; Tsironidou V; Rafail S; Kartalis G; Speletas M; Ritis K
Clin Genet; 2007 May; 71(5):458-67. PubMed ID: 17489852
[TBL] [Abstract][Full Text] [Related]
16. Common MEFV mutation analysis in 36 Iranian patients with familial Mediterranean fever: clinical and demographic significance.
Bidari A; Ghavidel-Parsa B; Najmabadi H; Talachian E; Haghighat-Shoar M; Broumand B; Ghalehbaghi B
Mod Rheumatol; 2010 Dec; 20(6):566-72. PubMed ID: 20549290
[TBL] [Abstract][Full Text] [Related]
17. Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of 'intermediate risk'.
Fragouli E; Eliopoulos E; Petraki E; Sidiropoulos P; Aksentijevich I; Galanakis E; Kritikos H; Repa A; Fragiadakis G; Boumpas D; Goulielmos GN
Clin Genet; 2008 Feb; 73(2):152-9. PubMed ID: 18177465
[TBL] [Abstract][Full Text] [Related]
18. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H
Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations.
Moradian MM; Sarkisian T; Ajrapetyan H; Avanesian N
J Hum Genet; 2010 Jun; 55(6):389-93. PubMed ID: 20485448
[TBL] [Abstract][Full Text] [Related]
20. Familial Mediterranean fever without MEFV mutations: a case-control study.
Ben-Zvi I; Herskovizh C; Kukuy O; Kassel Y; Grossman C; Livneh A
Orphanet J Rare Dis; 2015 Mar; 10():34. PubMed ID: 25887307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
